By , MarketWatch BOSTON (MarketWatch) �� Abbott Laboratories reported a lower first-quarter profit early Wednesday due to assorted accounting charges associated with restructuring and acquisition costs. Shares of Abbott (NYSE:ABT) Donald Trump's...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Charges weigh on Abbott��s results
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account